HealthQuill Health
Understanding the genetic and environmental factors contributing to the development of Parkinson’s is crucial for improving prevention and treatment strategies. 
Climate Health Opinion Pharma

Opinion: Pesticide exposure and its link to Parkinson’s disease 

Understanding the genetic and environmental factors contributing to the development of Parkinson’s is crucial for improving prevention and treatment strategies. 

Read More
Drugs Health Medical

CDC issues travel advisory for meningitis for Haj pilgrims to KSA

HQ Team May 23, 2024: The US Centers for Disease Control and Prevention (CDC) has warned that Muslim pilgrims traveling for the annual.

Read More
Eli Lilly’s weight-loss injection Zepbound, taken along as a supplement with diet and exercise, got the USFDA and UK regulator’s nod after clinical trials proved adults lost 48 pounds on average during treatment.
Drugs Health Pharma

7-fold increase in use of GLP-1 weight loss drugs among teens, young adults

Research finds a sharp increase in use of weightloss drugs such as Ozempic and Wegovy among teens and young adults

Read More
The World Health Organization, after seven years, has updated its pathogens list which has 15 families of antibiotic-resistant bacteria grouped into critical, high and medium categories for prioritisation.
Drugs Health Pharma

WHO deletes five pathogen-antibiotic combinations in new list, adds four

The World Health Organization, after seven years, has updated its pathogens list which has 15 families of antibiotic-resistant bacteria grouped into critical, high.

Read More
Takeda Pharmaceutical’s subsidiary, Shire Plc., was granted an FDA nod for making generic chewable tablets to treat attention-deficit, hyperactivity disorder, and moderate to severe binge disorder in adults.
Drugs Health Medical

Vitamin D deficiency linked to cardiovascular, CKD morbidity

HQ Team May 20, 2024: Vitamin D deficiency is associated with poor outcomes in cardiovascular diseases and chronic kidney disease (CKD) in patients with early-stage.

Read More
AstraZeneca plans to build a $1.5 billion facility to make antibody-drug conjugates in Singapore, the company announced in a statement.
Drugs Health Pharma

AstraZeneca plans to build $1.5 billion drug making facility in Singapore 

HQ Team May 20, 2024: AstraZeneca plans to build a $1.5 billion facility to make antibody-drug conjugates in Singapore, the company announced in.

Read More
More than 1,700 people have died globally due to cholera in the four months ended April amid a shortage of vaccines because of a rise in demand, according to the World Health Organization, which has classified the outbreak as an emergency.
Drugs Health Pharma

Cholera kills 1,766 people in Jan-April period, vaccines in short supply 

HQ Team May 17, 2024: More than 1,700 people have died globally due to cholera in the four months ended April amid a.

Read More
A measles vaccine given to a child born by caesarean section is likely to be 2.6 times completely ineffective than a normal delivery, a study by the University of Cambridge found.
Drugs Health Pharma

Birth by C-section may double the chance of measles vaccine failure

HQ Team May 17, 2024: A measles vaccine given to a child born by caesarean section is likely to be 2.6 times completely.

Read More
The US Food and Drug Administration has cleared Amgen’s drug to treat adult patients in the extensive stages of small cell lung cancer (ES-SCLC) with disease progression on or after chemotherapy.
Drugs Health Pharma

USFDA gives nod to Amgen’s therapy for treating small cell lung cancer 

HQ Team May 17, 2024: The US Food and Drug Administration has cleared Amgen’s drug to treat adult patients in the extensive stages.

Read More
Johnson & Johnson will acquire Proteologix, Inc., a privately-held biotechnology company, for $850 million in cash, according to a statement.
Drugs Health Pharma

Johnson & Johnson to buy Proteologix Inc., for $850 million in cash

HQ Team May 17, 2024: Johnson & Johnson will acquire Proteologix, Inc., a privately-held biotechnology company, for $850 million in cash, according to.

Read More